SON-3015

N/A

Report date: 2024/01/29 17:45:41

Base Information

Drug NameSON-3015
Drug Alias NameSON-3015Anti-IL6-FHAB-Anti-TGFβ
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTransforming growth factor beta inhibitorsInterleukin-6 inhibitors
TargetsTransforming growth factor betaInterleukin-6
Therapy Area/IndicationsBone metastasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonnet Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsBone metastases
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A